Allarity Therapeutics, Inc. Common Stock (NASDAQ: ALLR) last traded at $1.42, down 0.70% on the session. The quote above updates while this page is open; the figures below are drawn from Allarity Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Allarity Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ALLR. Its market capitalisation is $22.59 million.
Valuation measures for Allarity Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $22.59M |
|---|---|
| Enterprise value | $34.19M |
| Price / sales | 70.60 |
| Price / book | 6.39 |
| Beta | 1.72 |
Trailing-twelve-month figures tagged in Allarity Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $320.0K |
|---|---|
| Net income (TTM) | -$12.33M |
| EPS (TTM) | -$0.760 |
| Operating margin | -3373.44% |
| Return on equity | -348.81% |
| Cash | $16.98M |
Range and volume for ALLR over the past 52 weeks.
| 52-week high | $2.35 |
|---|---|
| 52-week low | $0.769 |
| Volume | 111.2K |
| Average volume | 135.3K |
| Previous close | $1.43 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.